经济观察网微电生理于2026年2月12日发布2025年年度业绩快报，显示公司2025年实现营业总收入 46,453.20万元，同比增长12.43%；归属于母公司所有者的净利润5,115.17万元，同比下降1.76%。扣除 非经常性损益的净利润2,365.80万元，较2024年大幅增长。业绩增长主要得益于海外收入同比增幅超 40%，占总收入比例已超30%，国际化战略推进显著；国内业务中，压力监测射频消融导管使用量同比 增长超70%，推动高端术式升级。公司提示数据为初步核算，最终以年报为准。 近期事件 近期股价震荡整理，截至2026年2月12日收盘报23.50元，近7日(2月5日至12日)区间涨跌幅0.95%，振幅 4.64%。2月11日因业绩快报披露当日下跌1.43%，成交额5887.93万元；2月12日资金面显示主力净流出 510.58万元，散户资金活跃。所属医疗器械板块同期下跌0.83%，表现弱于大盘。 以上内容基于公开资料整理，不构成投资建议。 限售股解禁：2026年2月11日公告，约3.46亿股限售股将于2026年3月2日上市流通，占公司总股本 73.47%，可能对股价形成流动性压力。 股票近期走势 产 ...

近日，微电生理发布公告称，公司的磁导航消融导管及星型高密度标测导管于近日获得了欧盟医疗器械 法规（MDR）认证证书。 此次认证将助力公司进入欧洲市场，依托高附加值产品进一步扩大海外收入规模，并完善海外"标测 +消融"技术矩阵。 ...

Important Matters - Evert plans to acquire 100% of Shengpu shares, with stock resuming trading on February 10 [1] - Hainan Mining intends to acquire 69.9% stake in Fengrui Fluorine Industry, with stock resuming trading on February 10 [1] - Runtou Co., which has seen its core product disperse dye prices rise by approximately 5000 yuan per ton recently, has achieved two consecutive trading limit increases [1] - Zhejiang Longsheng has announced another price adjustment for certain types of disperse dyes on February 8, with price sustainability dependent on supply and demand [1] - Taisheng Wind Power's rocket fuel storage tank production line is designed for an annual capacity of 60 tanks, expected to be operational by mid-2026 [1] - Dingsheng Technology has signed a cooperation framework agreement with Huineng Technology for solid-state batteries and the new energy industry [1] - Microelectrophysiology has received EU MDR certification for its magnetic navigation ablation catheter and star high-density mapping catheter [1] - Yuandong Bio has completed the first dosing of the Phase I clinical trial for the EP-0210 monoclonal antibody injection [1] - Xinyi Sheng has mass-produced and delivered 1.6T optical modules, while advancing the development of 3.2T, 6.4T, and 12.8T products [1] Investments, Contracts, and Collaborations - Mengguli plans to invest 929 million yuan to build a project for an annual production of 30,000 tons of lithium-ion battery cathode materials [1] - Zhiguang Electric's subsidiary has signed a 1.004 billion yuan contract for energy storage systems [1] - Daily Interaction's wholly-owned subsidiary intends to increase capital by 10 million yuan in Yuntong Shuda [1] - Jinhui Co. plans to acquire 100% of Fusheng Mining for 210 million yuan, which holds a gold mining right with an annual production capacity of 50,000 tons [1] - Yuanjie Technology intends to invest 1.251 billion yuan to build a second-phase research and production base for optoelectronic communication semiconductors, focusing on high-speed optical chips [1] - Zhongke Shuguang plans to issue convertible bonds to raise no more than 8 billion yuan for advanced computing cluster systems aimed at artificial intelligence [1] Share Buybacks - Huitai Medical plans to repurchase shares worth 150 million to 200 million yuan for employee stock ownership plans or equity incentives [2] - Kaiying Network intends to repurchase shares worth 100 million to 200 million yuan [2] - Dianzhi Technology plans to repurchase shares worth 100 million to 200 million yuan [2]

Group 1 - Huatai Medical plans to repurchase shares worth between 150 million to 200 million yuan for employee stock ownership plans or equity incentives, with a repurchase price not exceeding 315 yuan per share [1][3] - Aopt plans to raise no more than 1.38 billion yuan for projects related to AI intelligent vision solutions and industrial 3D vision sensors [1][4] - Weimais reported a net profit of 557 million yuan for 2025, a year-on-year increase of 39.22%, despite a slight decline in total revenue [1][6] Group 2 - Jiaokong Technology signed a contract for the Sydney Metro West Line TSMO signal system subcontract project, with a contract value of approximately 93.53 million Australian dollars [1][5] - Microelectrophysiology received EU MDR certification for its magnetic navigation ablation catheter and star-shaped high-density mapping catheter, facilitating entry into the European market [1][4] - Firmus Technologies, an Australian AI infrastructure company, secured 10 billion USD in debt financing led by Blackstone for data center expansion [8][9]

公司磁导航消融导管及星型高密度标测导管获欧盟MDR认证，不仅助力公司进入欧洲市场，依托高附 加值产品进一步扩大海外收入规模，还完善了公司海外"标测+消融"技术矩阵，与现有三维标测系统形 成完整解决方案，强化了全能量消融技术壁垒，同时凭借精准、高效、安全的产品特性提升客户粘性、 夯实全球化品牌认知，为产品快速出海奠定了坚实基础。 格隆汇2月9日丨微电生理(688351.SH)公布，公司磁导航消融导管及星型高密度标测导管于近日获得了 欧盟医疗器械法规(The Medical DeviceRegulations (EU) 2017/745，以下简称"MDR")认证证书。 ...

Core Viewpoint - Microelectrophysiology has received EU MDR certification for its magnetic navigation ablation catheter and star-shaped high-density mapping catheter, which will facilitate entry into the European market and expand overseas revenue [1] Group 1: Product Certification - The company announced that its magnetic navigation ablation catheter and star-shaped high-density mapping catheter have obtained EU MDR certification [1] - This certification is expected to enhance the company's overseas "mapping + ablation" technology matrix [1] Group 2: Market Impact - The entry into the European market is anticipated to increase the company's overseas revenue scale [1] - However, sales in international markets may be affected by uncertainties such as foreign regulatory policies, market environment changes, and exchange rate fluctuations [1] - The company is currently unable to predict the specific impact of these factors on its future business [1]

格隆汇2月9日｜微电生理公告，公司磁导航消融导管及星型高密度标测导管于近日获得了欧盟医疗器械 法规（TheMedicalDevice Regulations (EU) 2017/745，简称"MDR"）认证证书。 ...